![Atezolizumab bests chemo in NSCLC patients with high PD-L1 expression | MDedge Hematology and Oncology Atezolizumab bests chemo in NSCLC patients with high PD-L1 expression | MDedge Hematology and Oncology](https://cdn.mdedge.com/files/s3fs-public/styles/teaser_opengraph/public/Giaccone_Giuseppe_DC_143563_web.jpg)
Atezolizumab bests chemo in NSCLC patients with high PD-L1 expression | MDedge Hematology and Oncology
![Current treatment paradigm and future prospects for extensive-stage small cell lung cancer in the relapsed setting Current treatment paradigm and future prospects for extensive-stage small cell lung cancer in the relapsed setting](https://touchoncology.com/wp-content/uploads/sites/2/2021/03/Prof-Owonikoko-scaled-e1616665227212.jpg)
Current treatment paradigm and future prospects for extensive-stage small cell lung cancer in the relapsed setting
Giuseppe Giaccone, Muriel Lipit and Michael Lipit attend the Lung... Fotografía de noticias - Getty Images
![Giuseppe Giaccone: Leading Clinical Oncology Research Expansion | Georgetown University Medical Center | Georgetown University Giuseppe Giaccone: Leading Clinical Oncology Research Expansion | Georgetown University Medical Center | Georgetown University](https://gumc.georgetown.edu/wp-content/uploads/2018/11/Gia.jpg)